Phase 3 High Risk Smoldering Multiple Myeloma (HR-SMM) Clinical Trials
1 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.